CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
Endoscopic Retrograde Cholangiopancreatography +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03775681
NCT03775681N/ACompleted
CompareCT.gov

Is the Gastro LMA a Feasible Alternative to the Use of a Native Airway for Endoscopic Retrograde Cholangiopancreatography (ERCP) Cases?

M.D. Anderson Cancer Center·interventional·Posted Dec 14, 2018·Updated Apr 27, 2021

In Brief

A clinical study evaluating Endoscopic Retrograde Cholangiopancreatography, Interview, and 1 other intervention for Bile Duct Disorder and Endocrine Pancreas Disorder. Completed, enrolled 33 participants across 1 site.

Detailed Summary

This trial determines the feasibility of Laryngeal Mask Airway Gastro (Laryngeal Mask Airway) when used on patients who are undergoing endoscopic retrograde cholangiopancreatography for pancreas and bile duct disorders. Laryngeal Mask Airway is a device that helps patients breathe while they are asleep during procedures.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBile Duct Disorder, Endocrine Pancreas Disorder
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 14, 2018
Enrollment StartJan 16, 2019
Primary CompletionApr 20, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.5 years ago

Interventions

Endoscopic Retrograde Cholangiopancreatographyprocedure

Undergo standard of care ERCP

Interviewother

Ancillary studies

Laryngeal Mask Airwaydevice

Wear LMA